Yu Huang

机构：Shanghai University, Sun Yat-sen University, Xiamen University, Vanderbilt University, Lanzhou University of Technology, Beijing VDJBio (China), Shanghai CASB Biotechnology (China), Guangzhou First People's Hospital, Affiliated Hospital of Youjiang Medical University for Nationalities, Southwest Hospital, Putian University, Guangzhou Medical University · ORCID：0000-0002-6668-0702

发表论文 73 篇 · 总被引 688 次 · h-index 14

代表论文

• AI-assisted multi-modal information for the screening of depression: a systematic review and meta-analysis (2025 · npj Digital Medicine · 被引 25)
• Investigation of the optimal indocyanine green dose in real-time fluorescent cholangiography during laparoscopic cholecystectomy with an ultra-high-definition 4K fluorescent system: a randomized controlled trial (2023 · Updates in Surgery · 被引 14)
• Glycolytic regulatory enzyme PFKFB3 as a prognostic and tumor microenvironment biomarker in human cancers (2023 · Aging · 被引 14)
• Asperuloside as a Novel NRF2 Activator to Ameliorate Endothelial Dysfunction in High Fat Diet-Induced Obese Mice (2024 · Antioxidants and Redox Signaling · 被引 10)
• A multi-strategy platform for Q-markers screening and quality control of Wuzi Yanzong Wan based on fingerprint and network pharmacology (2023 · Arabian Journal of Chemistry · 被引 9)
• Sodium butyrate alleviates colitis by inhibiting mitochondrial ROS mediated macrophage pyroptosis (2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 被引 6)